These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 340733)

  • 1. Antitumor activity of protoplast membrane from group A streptococcus.
    Koshimura S; Ryoyama K; Ogawa H; Yamamoto A; Usami H; Mitsui H; Takagaki Y
    Jpn J Exp Med; 1977 Oct; 47(5):341-9. PubMed ID: 340733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced antitumor and immune-adjuvant activities of the sub-cellular fractions from Group A Streptococcus.
    Ryoyama K; Natsuume-Sakai S; Hirota H; Koshimura S
    Jpn J Exp Med; 1981 Dec; 51(6):335-44. PubMed ID: 7040746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitumor effect of synthetic cord factor analogue, 6, 6'-Di-O-decanoyl-alpha, alpha-trehalose].
    Ishii F; Takano S; Kohya H; Ishida N
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1629-34. PubMed ID: 6548105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
    Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
    Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
    Sur P; Bag SP; Sur B; Khanam JA
    Neoplasma; 1997; 44(3):197-201. PubMed ID: 9372863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkylphosphonium salts as a new class of antitumor agents.
    Sanyal U; Chatterjee RS; Das SK; Chakraborti SK
    Neoplasma; 1984; 31(2):149-55. PubMed ID: 6717684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fraction isolated from Ehrlich ascites carcinoma as an antitumor and differentiating agent against human leukemic cell ML-2.
    Sur P; Nandi N; Ghosh P; Ghosh NC
    Neoplasma; 2000; 47(2):114-7. PubMed ID: 10985477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic and antitumor effect of a fraction from cell-free extract of group A Streptococcus on transplantable tumor cells.
    Higuchi Y; Shoin S
    Anticancer Res; 1987; 7(6):1251-6. PubMed ID: 3327452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor actions of imidazolyl-(4-oxoquinazolin-3(4H)-yl)-acetamides against Ehrlich Ascites Carcinoma.
    Raghavendra NM; Gurubasavarajaswamy PM; Nagaranavile KS; Parameshwaran T
    Arch Pharm Res; 2009 Mar; 32(3):431-6. PubMed ID: 19387588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor organometallics. I. Activity of some diphenyltin(IV) and diphenylantimony(III) derivatives on in vitro and in vivo Ehrlich ascites tumor.
    Bara A; Socaciu C; Silvestru C; Haiduc I
    Anticancer Res; 1991; 11(4):1651-5. PubMed ID: 1836124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging of mouse Ehrlich carcinoma growth inhibition by thiacarpine, an analogue of cytotoxic marine alkaloid polycarpine.
    Agafonova IG; Radchenko OS; Novikov VL; Aminin DL; Stonik VA
    Magn Reson Imaging; 2008 Jul; 26(6):763-9. PubMed ID: 18467060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of recombinant human tumor necrosis factor-alpha on Ehrlich ascites tumor growth.
    Terlikowski S; Sulkowska M; Nowak HF
    J Environ Pathol Toxicol Oncol; 2002; 21(1):87-92. PubMed ID: 11934018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An analysis of the connection between the inhibition of NAD biosynthesis and the antitumor activity of drugs].
    Reztsova VV; Filov VA; Stukov AN
    Vopr Onkol; 1992; 38(6):718-23. PubMed ID: 1300772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The dose-dependent cytogenetic and growth-inhibiting effects of a new antitumor preparation from the nitrosourea group].
    Fomina MM; Dzhamanbaev ZhA; Ostrovskaia LA
    Izv Akad Nauk SSSR Biol; 1991; (3):436-44. PubMed ID: 1955617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapeutic potential of the volatile oils from Zanthoxylum rhoifolium Lam leaves.
    da Silva SL; Figueiredo PM; Yano T
    Eur J Pharmacol; 2007 Dec; 576(1-3):180-8. PubMed ID: 17716654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effect of Bothrops jararaca venom.
    da Silva RJ; da Silva MG; Vilela LC; Fecchio D
    Mediators Inflamm; 2002 Apr; 11(2):99-104. PubMed ID: 12061431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the anticancer property of a new alpha-methylene-gamma-lactone derivative of phthalimide.
    Sanyal U; Dutta S; Das H
    Neoplasma; 1995; 42(3):129-32. PubMed ID: 7637822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence on chain length of antitumor activity of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes, IFO 13140, and its acid-degraded products.
    Sasaki T; Abiko N; Sugino Y; Nitta K
    Cancer Res; 1978 Feb; 38(2):379-83. PubMed ID: 620409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
    Myers CE; Young RC; Chabner BA
    Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.